全文获取类型
收费全文 | 151377篇 |
免费 | 31256篇 |
国内免费 | 2399篇 |
专业分类
耳鼻咽喉 | 5175篇 |
儿科学 | 5433篇 |
妇产科学 | 2478篇 |
基础医学 | 3225篇 |
口腔科学 | 1651篇 |
临床医学 | 26664篇 |
内科学 | 47295篇 |
皮肤病学 | 7458篇 |
神经病学 | 14766篇 |
特种医学 | 6360篇 |
外国民族医学 | 2篇 |
外科学 | 41059篇 |
综合类 | 276篇 |
现状与发展 | 72篇 |
一般理论 | 1篇 |
预防医学 | 7078篇 |
眼科学 | 3331篇 |
药学 | 979篇 |
中国医学 | 15篇 |
肿瘤学 | 11714篇 |
出版年
2024年 | 685篇 |
2023年 | 4792篇 |
2022年 | 1197篇 |
2021年 | 3080篇 |
2020年 | 6025篇 |
2019年 | 2161篇 |
2018年 | 7375篇 |
2017年 | 7334篇 |
2016年 | 8403篇 |
2015年 | 8404篇 |
2014年 | 15480篇 |
2013年 | 15605篇 |
2012年 | 5450篇 |
2011年 | 5473篇 |
2010年 | 10358篇 |
2009年 | 14237篇 |
2008年 | 5790篇 |
2007年 | 3986篇 |
2006年 | 6467篇 |
2005年 | 3739篇 |
2004年 | 3030篇 |
2003年 | 1987篇 |
2002年 | 2083篇 |
2001年 | 3838篇 |
2000年 | 3068篇 |
1999年 | 3243篇 |
1998年 | 3660篇 |
1997年 | 3467篇 |
1996年 | 3373篇 |
1995年 | 3212篇 |
1994年 | 1960篇 |
1993年 | 1583篇 |
1992年 | 1402篇 |
1991年 | 1435篇 |
1990年 | 1073篇 |
1989年 | 1209篇 |
1988年 | 1029篇 |
1987年 | 872篇 |
1986年 | 905篇 |
1985年 | 733篇 |
1984年 | 560篇 |
1983年 | 538篇 |
1982年 | 523篇 |
1981年 | 401篇 |
1980年 | 367篇 |
1979年 | 320篇 |
1978年 | 346篇 |
1977年 | 415篇 |
1975年 | 291篇 |
1972年 | 315篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
31.
32.
33.
This review discusses treatment options for men with premature ejaculation (PE), a common sexual dysfunction characterized
by short ejaculatory latency, decreased sexual satisfaction, and distress. For a number of reasons, including embarrassment
and the belief that PE is a normal part of aging, that it has no effective treatment, or that it will resolve itself, few
men with PE seek treatment. Although several treatment options exist (eg, behavioral, cognitive, and sex therapy methods;
desensitizing drugs; off-label use of antidepressants, phosphodiesterase type 5 inhibitors, or à-blockers), the majority of
men with PE are not satisfied with their results. New pharmacologic drugs develped specifically for the treatment of PE are
undergoing evaluation in clinical trials. For example, recent clinical research studies have revealed on-demand administration
of one such drug, dapoxetine, which achieved significant improvements in ejaculatory latency, control over ejaculation, and
satisfaction with sexual intercourse. In addition, partners of men who received dapoxetine likewise reported improved satisfaction
with sexual intercourse. Future studies may reveal that integration of pharmacologic drugs with psychologic and/or behavioral
therapy techniques may be the optimal approach to the management of PE. PE is a treatable condition, and new drugs in development
may provide benefits over those available. 相似文献
34.
35.
36.
37.
38.
OBJECTIVE: To compare infants' discomfort, nursing-time and caregiver preference, and assess the clinical efficiency (as a secondary outcome) of hood versus facemask nebulization in infants with evolving bronchopulmonary dysplasia (BPD) in the neonatal intensive care unit. STUDY DESIGN: A prospective, open, randomized, controlled crossover clinical trial. In total, 10 infants with BPD who were on inhaled beta-agonist bronchodilators and corticosteroids were randomly assigned to receive their nebulized treatments either by a facemask, or by a hood for 2-3 days, and then crossover to receive the same treatments with the other technique for another 2-3 days. Infants' discomfort, nursing-time, caregiver preference and clinical efficiency were compared. RESULTS: At baseline there was no significant clinical difference between the groups. Nurse-time required for administering the hood nebulization (mean+/-s.e.m.: 1.9+/-0.1 min) was significantly shorter than the time for mask nebulization (12.0+/-0.6 min, P<0.0001). Infants' discomfort score was significantly lower (0.1+/-0.04) for hood versus mask nebulization (2.5+/-0.2, P<0.0001). Nurses and parents unequivocally preferred the hood treatment. During both mask and hood nebulization therapies (2-3 days) clinical efficiency was comparable. While both methods caused an immediate (20 min post) clinical improvement, the immediate respiratory assessment change score was significantly greater for the hood versus the mask nebulization (0.62+/-0.27 versus 0.13+/-0.14, P<0.05). CONCLUSIONS: Nebulization of aerosolized medications in infants with evolving BPD by hood was less time-consuming for caregivers and was much better tolerated by the infants while being at least as effective as the conventional facemask nebulization. 相似文献
39.
Prostatitis and male infertility are frequent disorders, and the role of prostatitis in male infertility has been under discussion for more than 30 years. Many researchers have shown relevant links between the two. Although a causal relationship has not been definitely demonstrated, increasing evidence shows that chronic prostatitis has a relevant negative impact on male fertility potential, at least in certain subgroups. In the following review, we focus on the present state of knowledge on the role of chronic prostatitis as an etiologic factor in male infertility. 相似文献
40.
J. Curtis Nickel MD 《Current Prostate Reports》2006,4(3):132-137
Medical therapy is currently the most popular treatment choice for lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). Because medical therapy of BPH-related LUTS is considered a life-long strategy, short- and long-term cost considerations should play a major role in therapeutic decision-making. The effectiveness in terms of long and short amelioration of symptoms, flow rate, and quality of life are well documented for 5α-blockers and 5α-reductase inhibitors as well as for the gold standard treatment for BPH, transurethral resection of the prostate and minimally invasive therapies. Short-and long-term safety concerns also are well documented for these various treatment options. On the contrary, short- and long-term costs have been less well studied and comparisons depend on the model or analyses undertaken in the few studies available. However, the economic studies based on prospective clinical trial data that have become available throughout the past several decades allow us to rationalize our use of α-blockers, 5α -reductase inhibitors, and combination therapy, taking into consideration age, severity of symptoms, prostate volume, prostate-specific antigen, and the differential response of the various medications (and combination) in selected patients. Based on current studies, 5α -blockers generally provide cost-effective therapy for most patients, whereas 5α-reductase therapy and combination therapy provide cost-effective treatment for patients with larger prostate glands or higher baseline prostate-specific antigen levels. 相似文献